These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1721488
1. Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique. Figge J, Bakst G, Weisheit D, Solis O, Ross JS. Am J Pathol; 1991 Dec; 139(6):1213-9. PubMed ID: 1721488 [Abstract] [Full Text] [Related]
2. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. Holm R, Nesland JM. J Pathol; 1994 Mar; 172(3):267-72. PubMed ID: 8195930 [Abstract] [Full Text] [Related]
3. Cytoplasmic biotin-like activity interferes with immunohistochemical analysis of thyroid lesions: a comparison of antigen retrieval methods. Kashima K, Yokoyama S, Daa T, Nakayama I, Nickerson PA, Noguchi S. Mod Pathol; 1997 May; 10(5):515-9. PubMed ID: 9160320 [Abstract] [Full Text] [Related]
5. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A. Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634 [Abstract] [Full Text] [Related]
6. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin. Kavishwar VS, Phatak AM, Rege JD. Indian J Pathol Microbiol; 1998 Apr 15; 41(2):163-7. PubMed ID: 9670628 [Abstract] [Full Text] [Related]
7. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Diaz NM, Mazoujian G, Wick MR. Arch Pathol Lab Med; 1991 Dec 15; 115(12):1203-7. PubMed ID: 1768209 [Abstract] [Full Text] [Related]
8. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Satacińska-Los E, Kulig A, Włoch J. Pol J Pathol; 2005 Dec 15; 56(1):27-35. PubMed ID: 15921011 [Abstract] [Full Text] [Related]
9. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C, Slamon DJ. Oncogene; 1993 Jul 15; 8(7):1913-9. PubMed ID: 8390038 [Abstract] [Full Text] [Related]
10. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J. Anticancer Res; 1998 Jul 15; 18(4A):2637-41. PubMed ID: 9703921 [Abstract] [Full Text] [Related]
11. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland. Czyz W, Joensuu H, Pylkkänen L, Klemi PJ. J Pathol; 1994 Dec 15; 174(4):267-74. PubMed ID: 7884588 [Abstract] [Full Text] [Related]
12. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma. de Souza Meyer EL, Dora JM, Wagner MS, Maia AL. Clin Endocrinol (Oxf); 2005 Jun 15; 62(6):672-8. PubMed ID: 15943828 [Abstract] [Full Text] [Related]
13. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Vargas MP, Vargas HI, Kleiner DE, Merino MJ. Mod Pathol; 1997 Jan 15; 10(1):12-7. PubMed ID: 9021722 [Abstract] [Full Text] [Related]
14. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu SX, Benedict WF, Sekiya T. Cancer Res; 1994 Aug 01; 54(15):4177-82. PubMed ID: 8033150 [Abstract] [Full Text] [Related]
15. Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma. Boltze C, Schneider-Stock R, Quednow C, Gerlach R, Mawrin C, Hinze R, Roessner A, Hoang-Vu C. Int J Oncol; 2003 Nov 01; 23(5):1323-8. PubMed ID: 14532972 [Abstract] [Full Text] [Related]
16. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O. Mod Pathol; 1998 Aug 01; 11(8):735-9. PubMed ID: 9720501 [Abstract] [Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors. Lewy-Trenda I, Wierzchniewska-Ławska A. Pol J Pathol; 2002 Aug 01; 53(3):129-32. PubMed ID: 12476614 [Abstract] [Full Text] [Related]
18. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Anticancer Res; 2003 Aug 01; 23(5A):3819-24. PubMed ID: 14666683 [Abstract] [Full Text] [Related]
19. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM. Arch Otolaryngol Head Neck Surg; 2008 Jun 01; 134(6):581-6. PubMed ID: 18559722 [Abstract] [Full Text] [Related]
20. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA. Mol Carcinog; 1996 Feb 01; 15(2):85-95. PubMed ID: 8599583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]